Page last updated: 2024-11-03

propranolol and Plasma Cell Tumor

propranolol has been researched along with Plasma Cell Tumor in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalinichenko, VV1
Mokyr, MB1
Graf, LH1
Cohen, RL1
Chambers, DA1
Grzanna, R1
Frondoza, CG1
Hung, GL1
Sastre, A1

Other Studies

2 other studies available for propranolol and Plasma Cell Tumor

ArticleYear
Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.
    Journal of immunology (Baltimore, Md. : 1950), 1999, Sep-01, Volume: 163, Issue:5

    Topics: Animals; Antigens, Differentiation; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocy

1999
In vivo administration of propranolol delays development of a murine plasmacytoma tumor.
    Journal of the autonomic nervous system, 1985, Volume: 14, Issue:4

    Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Female; Immunoglobulin G; Mice; Mice, Inbred BA

1985